Terumo Corporation

2-44-1, Hatagaya Shibuya-ku,
Tokyo, 151-0072
81 3 3374 8111

Terumo Corporation is a medical products company based in Japan. It was formed in 1921.

M&A Summary

Buy vs Sell

Year ≤ '13 '14 '15 '16 '17 '18 T
Buy (0.6/yr) # 4 - - 3 - - 7
vol $2.6B $280M $2.9B
Sell (0.0/yr) # 1 - - - - - 1
vol $57M $57M

Top M&A Advisors

Financial Deals
Join to Access.
Legal Deals
Join to Access.

Deal Values

> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest CaridianBCT
$2.6B (2011-03-07)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View
Largest Terumo-DuraHeart II (DH-II) Ventricular Assist System
$57M (2013-07-01)

According to our data here at Mergr, Terumo has acquired 8 companies, including 3 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 1 asset.

Terumo’s largest acquisition to date was in 2011, when it acquired CaridianBCT for $2.6B. It’s largest disclosed sale occurred in 2013, when it sold Terumo-DuraHeart II Ventricular Assist System to Thoratec for $57M. Terumo has acquired in 5 different US states, and 2 countries. The Company’s most targeted sectors include medical products (86%) and healthcare services (15%).

When analyzing the medical products sector as a whole, according to Mergr, in the last 3 years, there are 337 medical products companies that have made at least 1 acquisition, 16 have acquired at least 5 companies, and 2 have acquired more than 10 companies. The most prolific strategic medical products acquirer over the past 3 years is Boston Scientific, with 13 acquisitions. The most prolific private equity acquirer in the medical products sector over the past 3 years is Apax Partners with 4 platform acquisitions.

Join Mergr and gain access to Terumo’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the medical products sector.

What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.4K Private Equity Firms
  • 120K M&A Transactions
  • 129K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.